MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
336.23
-0.22
-0.07%
Pre Market: 336.35 +2.64 +0.79% 07:38 05/15 EDT
OPEN
336.26
PREV CLOSE
336.45
HIGH
337.94
LOW
333.47
VOLUME
860
TURNOVER
511.89M
52 WEEK HIGH
391.29
52 WEEK LOW
253.48
MARKET CAP
181.47B
P/E (TTM)
23.38
1D
5D
1M
3M
1Y
5Y
1D
Sino Biopharmaceutical Stock Slides 3.6% in Hong Kong, Underperforms Competitors
Dow Jones · 3h ago
2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down
Barchart · 9h ago
Notable Thursday Option Activity: AMGN, FG, PANW
NASDAQ · 16h ago
Biopharmas look to China, elsewhere for partnerships, R&D
Seeking Alpha · 17h ago
Strong biopharma dealmaking market set to continue
Seeking Alpha · 18h ago
Amgen Price Target Cut to $427.00/Share From $432.00 by Piper Sandler
Dow Jones · 20h ago
Amgen Is Maintained at Overweight by Piper Sandler
Dow Jones · 20h ago
Piper Sandler Maintains Overweight on Amgen, Lowers Price Target to $427
Benzinga · 20h ago
More
About AMGN
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.